                         SEQUENCE LISTING

<110>  Chimera Bioengineering, Inc.
 
<120>  Smart CAR Devices, DE CAR Polypeptides, Side CARs and Uses Thereof

<130>  CBI.011

<160>  53    

<170>  PatentIn version 3.5

<210>  1
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FKBP peptide

<400>  1

Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Phe Pro 
1               5                   10                  15      


Lys Arg Gly Gln Thr Cys Val Val His Tyr Thr Gly Met Leu Glu Asp 
            20                  25                  30          


Gly Lys Lys Phe Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys Phe 
        35                  40                  45              


Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Glu Glu Gly Val Ala 
    50                  55                  60                  


Gln Met Ser Val Gly Gln Arg Ala Lys Leu Thr Ile Ser Pro Asp Tyr 
65                  70                  75                  80  


Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro Pro His Ala Thr 
                85                  90                  95      


Leu Val Phe Asp Val Glu Leu Leu Lys Leu Glu 
            100                 105         


<210>  2
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FKBP variant peptide


<220>
<221>  Xaa
<222>  (15)..(15)
<223>  Xaa = Phe, Ser

<220>
<221>  Xaa
<222>  (24)..(24)
<223>  Xaa = Val, Ala

<220>
<221>  Xaa
<222>  (25)..(25)
<223>  Xaa = His, Arg

<220>
<221>  Xaa
<222>  (36)..(36)
<223>  Xaa = Phe, Val

<220>
<221>  Xaa
<222>  (60)..(60)
<223>  Xaa = Glu, Gly

<220>
<221>  Xaa
<222>  (66)..(66)
<223>  Xaa = Met, Thr

<220>
<221>  Xaa
<222>  (71)..(71)
<223>  Xaa = Arg, Gly

<220>
<221>  Xaa
<222>  (100)..(100)
<223>  Xaa = Asp, Gly, Asn

<220>
<221>  Xaa
<222>  (102)..(102)
<223>  Xaa = Glu, Gly

<220>
<221>  Xaa
<222>  (105)..(105)
<223>  Xaa = Lys, Ile

<220>
<221>  Xaa
<222>  (106)..(106)
<223>  Xaa = Leu, Pro

<400>  2

Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Xaa Pro 
1               5                   10                  15      


Lys Arg Gly Gln Thr Cys Val Xaa Xaa Tyr Thr Gly Met Leu Glu Asp 
            20                  25                  30          


Gly Lys Lys Xaa Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys Phe 
        35                  40                  45              


Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Xaa Glu Gly Val Ala 
    50                  55                  60                  


Gln Xaa Ser Val Gly Gln Xaa Ala Lys Leu Thr Ile Ser Pro Asp Tyr 
65                  70                  75                  80  


Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro Pro His Ala Thr 
                85                  90                  95      


Leu Val Phe Xaa Val Glu Leu Leu Xaa Xaa Glu 
            100                 105         


<210>  3
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FKBP variant polypeptide


<220>
<221>  Xaa
<222>  (1)..(107)
<223>  Xaa = any amino acid

<400>  3

Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Xaa Pro 
1               5                   10                  15      


Lys Arg Gly Gln Thr Cys Val Xaa Xaa Tyr Thr Gly Met Leu Glu Asp 
            20                  25                  30          


Gly Lys Lys Xaa Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys Phe 
        35                  40                  45              


Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Xaa Glu Gly Val Ala 
    50                  55                  60                  


Gln Xaa Ser Val Gly Gln Xaa Ala Lys Leu Thr Ile Ser Pro Asp Tyr 
65                  70                  75                  80  


Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro Pro His Ala Thr 
                85                  90                  95      


Leu Val Phe Xaa Val Glu Leu Leu Xaa Xaa Glu 
            100                 105         


<210>  4
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  divesity sequence peptide

<400>  4

Thr Arg Gly Val Glu Glu Val Ala Glu Gly Val Val Leu Leu Arg Arg 
1               5                   10                  15      


Arg Gly Asn 
            


<210>  5
<211>  159
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DHFR peptide

<400>  5

Met Ile Ser Leu Ile Ala Ala Leu Ala Val Asp His Val Ile Gly Met 
1               5                   10                  15      


Glu Asn Ala Met Pro Trp Asn Leu Pro Ala Asp Leu Ala Trp Phe Lys 
            20                  25                  30          


Arg Asn Thr Leu Asn Lys Pro Val Ile Met Gly Arg His Thr Trp Glu 
        35                  40                  45              


Ser Ile Gly Arg Pro Leu Pro Gly Arg Lys Asn Ile Ile Leu Ser Ser 
    50                  55                  60                  


Gln Pro Ser Thr Asp Asp Arg Val Thr Trp Val Lys Ser Val Asp Glu 
65                  70                  75                  80  


Ala Ile Ala Ala Cys Gly Asp Val Pro Glu Ile Met Val Ile Gly Gly 
                85                  90                  95      


Gly Arg Val Tyr Glu Gln Phe Leu Pro Lys Ala Gln Lys Leu Tyr Leu 
            100                 105                 110         


Thr His Ile Asp Ala Glu Val Glu Gly Asp Thr His Phe Pro Asp Tyr 
        115                 120                 125             


Glu Pro Asp Asp Trp Glu Ser Val Phe Ser Glu Phe His Asp Ala Asp 
    130                 135                 140                 


Ala Gln Asn Ser His Ser Tyr Cys Phe Glu Ile Leu Glu Arg Arg 
145                 150                 155                 


<210>  6
<211>  159
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DHFR variant peptide


<220>
<221>  Xaa
<222>  (12)..(12)
<223>  Xaa = His, Leu, Tyr

<220>
<221>  Xaa
<222>  (18)..(18)
<223>  Xaa = Asn, Thr

<220>
<221>  Xaa
<222>  (19)..(19)
<223>  Xaa = Ala, Val

<220>
<221>  Xaa
<222>  (42)..(42)
<223>  Xaa = Met, Thr

<220>
<221>  Xaa
<222>  (61)..(61)
<223>  Xaa = Ile, Phe

<220>
<221>  Xaa
<222>  (68)..(68)
<223>  Xaa = Thr, Ser

<220>
<221>  Xaa
<222>  (98)..(98)
<223>  Xaa = Arg, His

<220>
<221>  Xaa
<222>  (100)..(100)
<223>  Xaa = Tyr, Ile

<220>
<221>  Xaa
<222>  (103)..(103)
<223>  Xaa = Phe, Leu, Ser

<220>
<221>  Xaa
<222>  (114)..(114)
<223>  Xaa = His, Arg

<220>
<221>  Xaa
<222>  (121)..(121)
<223>  Xaa = Gly, Val

<400>  6

Met Ile Ser Leu Ile Ala Ala Leu Ala Val Asp Xaa Val Ile Gly Met 
1               5                   10                  15      


Glu Xaa Xaa Met Pro Trp Asn Leu Pro Ala Asp Leu Ala Trp Phe Lys 
            20                  25                  30          


Arg Asn Thr Leu Asn Lys Pro Val Ile Xaa Gly Arg His Thr Trp Glu 
        35                  40                  45              


Ser Ile Gly Arg Pro Leu Pro Gly Arg Lys Asn Ile Xaa Leu Ser Ser 
    50                  55                  60                  


Gln Pro Ser Xaa Asp Asp Arg Val Thr Trp Val Lys Ser Val Asp Glu 
65                  70                  75                  80  


Ala Ile Ala Ala Cys Gly Asp Val Pro Glu Ile Met Val Ile Gly Gly 
                85                  90                  95      


Gly Xaa Val Xaa Glu Gln Xaa Leu Pro Lys Ala Gln Lys Leu Tyr Leu 
            100                 105                 110         


Thr Xaa Ile Asp Ala Glu Val Glu Xaa Asp Thr His Phe Pro Asp Phe 
        115                 120                 125             


Glu Pro Asp Asp Trp Glu Ser Val Phe Ser Glu Phe His Asp Ala Asp 
    130                 135                 140                 


Ala Gln Asn Ser His Ser Tyr Cys Phe Glu Ile Leu Glu Arg Arg 
145                 150                 155                 


<210>  7
<211>  159
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DHFR variant peptide


<220>
<221>  Xaa
<222>  (1)..(159)
<223>  Xaa = any amino acid

<400>  7

Met Ile Ser Leu Ile Ala Ala Leu Ala Val Asp Xaa Val Ile Gly Met 
1               5                   10                  15      


Glu Xaa Xaa Met Pro Trp Asn Leu Pro Ala Asp Leu Ala Trp Phe Lys 
            20                  25                  30          


Arg Asn Thr Leu Asn Lys Pro Val Ile Xaa Gly Arg His Thr Trp Glu 
        35                  40                  45              


Ser Ile Gly Arg Pro Leu Pro Gly Arg Lys Asn Ile Xaa Leu Ser Ser 
    50                  55                  60                  


Gln Pro Ser Xaa Asp Asp Arg Val Thr Trp Val Lys Ser Val Asp Glu 
65                  70                  75                  80  


Ala Ile Ala Ala Cys Gly Asp Val Pro Glu Ile Met Val Ile Gly Gly 
                85                  90                  95      


Gly Xaa Val Xaa Glu Gln Xaa Leu Pro Lys Ala Gln Lys Leu Tyr Leu 
            100                 105                 110         


Thr Xaa Ile Asp Ala Glu Val Glu Xaa Asp Thr His Phe Pro Asp Phe 
        115                 120                 125             


Glu Pro Asp Asp Trp Glu Ser Val Phe Ser Glu Phe His Asp Ala Asp 
    130                 135                 140                 


Ala Gln Asn Ser His Ser Tyr Cys Phe Glu Ile Leu Glu Arg Arg 
145                 150                 155                 


<210>  8
<211>  273
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ERBD Peptide

<400>  8

Ser Leu Ala Leu Ser Leu Thr Ala Asp Gln Met Val Ser Ala Leu Leu 
1               5                   10                  15      


Asp Ala Glu Pro Pro Ile Leu Tyr Ser Glu Tyr Asp Pro Thr Arg Pro 
            20                  25                  30          


Phe Ser Glu Ala Ser Met Met Gly Leu Leu Thr Asn Leu Ala Asp Arg 
        35                  40                  45              


Glu Leu Val His Met Ile Asn Trp Ala Lys Arg Val Pro Gly Phe Val 
    50                  55                  60                  


Asp Leu Thr Leu His Asp Gln Val His Leu Leu Glu Cys Ala Trp Leu 
65                  70                  75                  80  


Glu Ile Leu Met Ile Gly Leu Val Trp Arg Ser Met Glu His Pro Gly 
                85                  90                  95      


Lys Leu Leu Phe Ala Pro Asn Leu Leu Leu Asp Arg Asn Gln Gly Lys 
            100                 105                 110         


Cys Val Glu Gly Met Val Glu Ile Phe Asp Met Leu Leu Ala Thr Ser 
        115                 120                 125             


Ser Arg Phe Arg Met Met Asn Leu Gln Gly Glu Glu Phe Val Cys Leu 
    130                 135                 140                 


Lys Ser Ile Ile Leu Leu Asn Ser Gly Val Tyr Thr Phe Leu Ser Ser 
145                 150                 155                 160 


Thr Leu Lys Ser Leu Glu Glu Lys Asp His Ile His Arg Val Leu Asp 
                165                 170                 175     


Lys Ile Thr Asp Thr Leu Ile His Leu Met Ala Lys Ala Gly Leu Thr 
            180                 185                 190         


Leu Gln Gln Gln His Gln Arg Leu Ala Gln Leu Leu Leu Ile Leu Ser 
        195                 200                 205             


His Ile Arg His Met Ser Asn Lys Gly Met Glu His Leu Tyr Ser Met 
    210                 215                 220                 


Lys Cys Lys Asn Val Val Pro Leu Tyr Asp Leu Leu Leu Glu Met Leu 
225                 230                 235                 240 


Asp Ala His Arg Leu Gly Gly Gly Ser Gly Gly Gly Ser Thr Arg Lys 
                245                 250                 255     


His Lys Ile Leu His Arg Leu Leu Gln Asp Ser Ser Arg Arg Arg Gly 
            260                 265                 270         


Asn 
    


<210>  9
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ERBD peptide

<400>  9

Ser Leu Ala Leu Ser Leu Thr Ala Asp Gln Met Val Ser Ala Leu Leu 
1               5                   10                  15      


Asp Ala Glu Pro Pro Ile Leu Tyr Ser Glu Tyr Asp Pro Thr Arg Pro 
            20                  25                  30          


Phe Ser Glu Ala Ser Met Met Gly Leu Leu Thr Asn Leu Ala Asp Arg 
        35                  40                  45              


Glu Leu Val His Met Ile Asn Trp Ala Lys Arg Val Pro Gly Phe Val 
    50                  55                  60                  


Asp Leu Thr Leu His Asp Gln Val His Leu Leu Glu Cys Ala Trp Leu 
65                  70                  75                  80  


Glu Ile Leu Met Ile Gly Leu Val Trp Arg Ser Met Glu His Pro Gly 
                85                  90                  95      


Lys Leu Leu Phe Ala Pro Asn Leu Leu Leu Asp Arg Asn Gln Gly Lys 
            100                 105                 110         


Cys Val Glu Gly Met Val Glu Ile Phe Asp Met Leu Leu Ala Thr Ser 
        115                 120                 125             


Ser Arg Phe Arg Met Met Asn Leu Gln Gly Glu Glu Phe Val Cys Leu 
    130                 135                 140                 


Lys Ser Ile Ile Leu Leu Asn Ser Gly Val Tyr Thr Phe Leu Ser Ser 
145                 150                 155                 160 


Thr Leu Lys Ser Leu Glu Glu Lys Asp His Ile His Arg Val Leu Asp 
                165                 170                 175     


Lys Ile Thr Asp Thr Leu Ile His Leu Met Ala Lys Ala Gly Leu Thr 
            180                 185                 190         


Leu Gln Gln Gln His Gln Arg Leu Ala Gln Leu Leu Leu Ile Leu Ser 
        195                 200                 205             


His Ile Arg His Met Ser Asn Lys Gly Met Glu His Leu Tyr Ser Met 
    210                 215                 220                 


Lys Cys Lys Asn Val Val Pro Leu Tyr Asp Leu Leu Leu Glu Met Leu 
225                 230                 235                 240 


Asp Ala His Arg Leu 
                245 


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  degron peptide

<400>  10

Arg Arg Arg Gly 
1               


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  bacterial degron peptide

<400>  11

Tyr Ala Leu Ala Ala 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  degron peptide

<400>  12

Arg Arg Arg Gly Asn 
1               5   


<210>  13
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  13

Lys His Lys Ile Leu His Arg Leu Leu Gln Asp Ser Ser 
1               5                   10              


<210>  14
<211>  144
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AsLOV2 peptide

<400>  14

Phe Leu Ala Thr Thr Leu Glu Arg Ile Glu Lys Asn Phe Val Ile Thr 
1               5                   10                  15      


Asp Pro Arg Leu Pro Asp Asn Pro Ile Ile Phe Ala Ser Asp Ser Phe 
            20                  25                  30          


Leu Gln Leu Thr Glu Tyr Ser Arg Glu Glu Ile Leu Gly Arg Asn Cys 
        35                  40                  45              


Arg Phe Leu Gln Gly Pro Glu Thr Asp Arg Ala Thr Val Arg Lys Ile 
    50                  55                  60                  


Arg Asp Ala Ile Asp Asn Gln Thr Glu Val Thr Val Gln Leu Ile Asn 
65                  70                  75                  80  


Tyr Thr Lys Ser Gly Lys Lys Phe Trp Asn Leu Phe His Leu Gln Pro 
                85                  90                  95      


Met Arg Asp Gln Lys Gly Asp Val Gln Tyr Phe Ile Gly Val Gln Leu 
            100                 105                 110         


Asp Gly Thr Glu His Val Arg Asp Ala Ala Glu Arg Glu Gly Val Met 
        115                 120                 125             


Leu Ile Lys Lys Thr Ala Glu Asn Ile Asp Glu Ala Ala Lys Glu Leu 
    130                 135                 140                 


<210>  15
<211>  144
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AsLOV2 variant peptide


<220>
<221>  Xaa
<222>  (14)..(14)
<223>  Xaa = Val, Ala, Ile

<220>
<221>  Xaa
<222>  (80)..(80)
<223>  Xaa = Asn, Lys, Arg

<220>
<221>  Xaa
<222>  (120)..(120)
<223>  Xaa = Asp, Glu, Ala

<220>
<221>  Xaa
<222>  (126)..(126)
<223>  Xaa = Gly, Ala

<220>
<221>  Xaa
<222>  (127)..(127)
<223>  Xaa = Val, Asn

<220>
<221>  Xaa
<222>  (130)..(130)
<223>  Xaa = Ile, Ala

<220>
<221>  Xaa
<222>  (136)..(136)
<223>  Xaa = Asn, Glu, Asp

<220>
<221>  Xaa
<222>  (142)..(142)
<223>  Xaa = Lys or No Amino Acid

<220>
<221>  Xaa
<222>  (143)..(143)
<223>  Xaa = Glu or No Amino Acid

<220>
<221>  Xaa
<222>  (144)..(144)
<223>  Xaa = Leu or No Amino Acid

<400>  15

Phe Leu Ala Thr Thr Leu Glu Arg Ile Glu Lys Asn Phe Xaa Ile Thr 
1               5                   10                  15      


Asp Pro Arg Leu Pro Asp Asn Pro Ile Ile Phe Ala Ser Asp Ser Phe 
            20                  25                  30          


Leu Gln Leu Thr Glu Tyr Ser Arg Glu Glu Ile Leu Gly Arg Asn Cys 
        35                  40                  45              


Arg Phe Leu Gln Gly Pro Glu Thr Asp Arg Ala Thr Val Arg Lys Ile 
    50                  55                  60                  


Arg Asp Ala Ile Asp Asn Gln Thr Glu Val Thr Val Gln Leu Ile Xaa 
65                  70                  75                  80  


Tyr Thr Lys Ser Gly Lys Lys Phe Trp Asn Leu Phe His Leu Gln Pro 
                85                  90                  95      


Met Arg Asp Gln Lys Gly Asp Val Gln Tyr Phe Ile Gly Val Gln Leu 
            100                 105                 110         


Asp Gly Thr Glu His Val Arg Xaa Ala Ala Glu Arg Glu Xaa Xaa Met 
        115                 120                 125             


Leu Xaa Lys Lys Thr Ala Glu Xaa Ile Asp Glu Ala Ala Xaa Xaa Xaa 
    130                 135                 140                 


<210>  16
<211>  144
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AsLOV2 variant peptide


<220>
<221>  Xaa
<222>  (1)..(144)
<223>  Xaa = any amino acid

<400>  16

Phe Leu Ala Thr Thr Leu Glu Arg Ile Glu Lys Asn Phe Xaa Ile Thr 
1               5                   10                  15      


Asp Pro Arg Leu Pro Asp Asn Pro Ile Ile Phe Ala Ser Asp Ser Phe 
            20                  25                  30          


Leu Gln Leu Thr Glu Tyr Ser Arg Glu Glu Ile Leu Gly Arg Asn Cys 
        35                  40                  45              


Arg Phe Leu Gln Gly Pro Glu Thr Asp Arg Ala Thr Val Arg Lys Ile 
    50                  55                  60                  


Arg Asp Ala Ile Asp Asn Gln Thr Glu Val Thr Val Gln Leu Ile Xaa 
65                  70                  75                  80  


Tyr Thr Lys Ser Gly Lys Lys Phe Trp Asn Leu Phe His Leu Gln Pro 
                85                  90                  95      


Met Arg Asp Gln Lys Gly Asp Val Gln Tyr Phe Ile Gly Val Gln Leu 
            100                 105                 110         


Asp Gly Thr Glu His Val Arg Xaa Ala Ala Glu Arg Glu Xaa Xaa Met 
        115                 120                 125             


Leu Xaa Lys Lys Thr Ala Glu Xaa Ile Asp Glu Ala Ala Xaa Xaa Xaa 
    130                 135                 140                 


<210>  17
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD3 zeta peptide

<400>  17

Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln 
1               5                   10                  15      


Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu 
            20                  25                  30          


Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly 
        35                  40                  45              


Lys Pro Gln Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu 
    50                  55                  60                  


Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly 
65                  70                  75                  80  


Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser 
                85                  90                  95      


Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro 
            100                 105                 110         


Pro Arg 
        


<210>  18
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fc epsilon receptor subunit gamma peptide

<400>  18

Arg Leu Lys Ile Gln Val Arg Lys Ala Ala Ile Thr Ser Tyr Glu Lys 
1               5                   10                  15      


Ser Asp Gly Val Tyr Thr Gly Leu Ser Thr Arg Asn Gln Glu Thr Tyr 
            20                  25                  30          


Glu Thr Leu Lys His Glu Lys Pro Pro Gln 
        35                  40          


<210>  19
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fc epsilon receptor subunit beta peptide

<400>  19

Ile Cys Gly Ala Gly Glu Glu Leu Lys Gly Asn Lys Val Pro Glu Asp 
1               5                   10                  15      


Arg Val Tyr Glu Glu Leu Asn Ile Tyr Ser Ala Thr Tyr Ser Glu Leu 
            20                  25                  30          


Glu Asp Pro Gly Glu Met Ser Pro Pro Ile Asp Leu 
        35                  40                  


<210>  20
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD3 gamma peptide

<400>  20

Gln Asp Gly Val Arg Gln Ser Arg Ala Ser Asp Lys Gln Thr Leu Leu 
1               5                   10                  15      


Pro Asn Asp Gln Leu Tyr Gln Pro Leu Lys Asp Arg Glu Asp Asp Gln 
            20                  25                  30          


Tyr Ser His Leu Gln Gly Asn Gln Leu Arg Arg Asn 
        35                  40                  


<210>  21
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD3 delta peptide

<400>  21

His Glu Thr Gly Arg Leu Ser Gly Ala Ala Asp Thr Gln Ala Leu Leu 
1               5                   10                  15      


Arg Asn Asp Gln Val Tyr Gln Pro Leu Arg Asp Arg Asp Asp Ala Gln 
            20                  25                  30          


Tyr Ser His Leu Gly Gly Asn Trp Ala Arg Asn Lys 
        35                  40                  


<210>  22
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD3 epsilon peptide

<400>  22

Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala 
1               5                   10                  15      


Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro 
            20                  25                  30          


Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser 
        35                  40                  45              


Gly Leu Asn Gln Arg Arg Ile 
    50                  55  


<210>  23
<211>  94
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD5 peptide

<400>  23

Tyr Lys Lys Leu Val Lys Lys Phe Arg Gln Lys Lys Gln Arg Gln Trp 
1               5                   10                  15      


Ile Gly Pro Thr Gly Met Asn Gln Asn Met Ser Phe His Arg Asn His 
            20                  25                  30          


Thr Ala Thr Val Arg Ser His Ala Glu Asn Pro Thr Ala Ser His Val 
        35                  40                  45              


Asp Asn Glu Tyr Ser Gln Pro Pro Arg Asn Ser His Leu Ser Ala Tyr 
    50                  55                  60                  


Pro Ala Leu Glu Gly Ala Leu His Arg Ser Ser Met Gln Pro Asp Asn 
65                  70                  75                  80  


Ser Ser Asp Ser Asp Tyr Asp Leu His Gly Ala Gln Arg Leu 
                85                  90                  


<210>  24
<211>  141
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD22 peptide

<400>  24

Lys Leu Gln Arg Arg Trp Lys Arg Thr Gln Ser Gln Gln Gly Leu Gln 
1               5                   10                  15      


Glu Asn Ser Ser Gly Gln Ser Phe Phe Val Arg Asn Lys Lys Val Arg 
            20                  25                  30          


Arg Ala Pro Leu Ser Glu Gly Pro His Ser Leu Gly Cys Tyr Asn Pro 
        35                  40                  45              


Met Met Glu Asp Gly Ile Ser Tyr Thr Thr Leu Arg Phe Pro Glu Met 
    50                  55                  60                  


Asn Ile Pro Arg Thr Gly Asp Ala Glu Ser Ser Glu Met Gln Arg Pro 
65                  70                  75                  80  


Pro Pro Asp Cys Asp Asp Thr Val Thr Tyr Ser Ala Leu His Lys Arg 
                85                  90                  95      


Gln Val Gly Asp Tyr Glu Asn Val Ile Pro Asp Phe Pro Glu Asp Glu 
            100                 105                 110         


Gly Ile His Tyr Ser Glu Leu Ile Gln Phe Gly Val Gly Glu Arg Pro 
        115                 120                 125             


Gln Ala Gln Glu Asn Val Asp Tyr Val Ile Leu Lys His 
    130                 135                 140     


<210>  25
<211>  61
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD79a peptide

<400>  25

Arg Lys Arg Trp Gln Asn Glu Lys Leu Gly Leu Asp Ala Gly Asp Glu 
1               5                   10                  15      


Tyr Glu Asp Glu Asn Leu Tyr Glu Gly Leu Asn Leu Asp Asp Cys Ser 
            20                  25                  30          


Met Tyr Glu Asp Ile Ser Arg Gly Leu Gln Gly Thr Tyr Gln Asp Val 
        35                  40                  45              


Gly Ser Leu Asn Ile Gly Asp Val Gln Leu Glu Lys Pro 
    50                  55                  60      


<210>  26
<211>  64
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD79b peptide

<400>  26

Thr Leu Leu Ile Ile Leu Phe Ile Ile Val Pro Ile Phe Leu Leu Leu 
1               5                   10                  15      


Asp Lys Asp Asp Ser Lys Ala Gly Met Glu Glu Asp His Thr Tyr Glu 
            20                  25                  30          


Gly Leu Asp Ile Asp Gln Thr Ala Thr Tyr Glu Asp Ile Val Thr Leu 
        35                  40                  45              


Arg Thr Gly Glu Val Lys Trp Ser Val Gly Glu His Pro Gly Pro Glu 
    50                  55                  60                  


<210>  27
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD66d peptide

<400>  27

Ala Lys Thr Gly Arg Thr Ser Ile Gln Arg Asp Leu Lys Glu Gln Gln 
1               5                   10                  15      


Pro Gln Ala Leu Ala Pro Gly Arg Gly Pro Ser His Ser Ser Ala Phe 
            20                  25                  30          


Ser Met Ser Pro Leu Ser Thr Ala Gln Ala Pro Leu Pro Asn Pro Arg 
        35                  40                  45              


Thr Ala Ala Ser Ile Tyr Glu Glu Leu Leu Lys His Asp Thr Asn Ile 
    50                  55                  60                  


Tyr Cys Arg Met Asp His Lys Ala Glu Val Ala Ser 
65                  70                  75      


<210>  28
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD2 peptide

<400>  28

Lys Arg Lys Lys Gln Arg Ser Arg Arg Asn Asp Glu Glu Leu Glu Thr 
1               5                   10                  15      


Arg Ala His Arg Val Ala Thr Glu Glu Arg Gly Arg Lys Pro His Gln 
            20                  25                  30          


Ile Pro Ala Ser Thr Pro Gln Asn Pro Ala Thr Ser Gln His Pro Pro 
        35                  40                  45              


Pro Pro Pro Gly His Arg Ser Gln Ala Pro Ser His Arg Pro Pro Pro 
    50                  55                  60                  


Pro Gly His Arg Val Gln His Gln Pro Gln Lys Arg Pro Pro Ala Pro 
65                  70                  75                  80  


Ser Gly Thr Gln Val His Gln Gln Lys Gly Pro Pro Leu Pro Arg Pro 
                85                  90                  95      


Arg Val Gln Pro Lys Pro Pro His Gly Ala Ala Glu Asn Ser Leu Ser 
            100                 105                 110         


Pro Ser Ser Asn 
        115     


<210>  29
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD4 peptide

<400>  29

Arg Cys Arg His Arg Arg Arg Gln Ala Glu Arg Met Ser Gln Ile Lys 
1               5                   10                  15      


Arg Leu Leu Ser Glu Lys Lys Thr Cys Gln Cys Pro His Arg Phe Gln 
            20                  25                  30          


Lys Thr Cys Ser Pro Ile 
        35              


<210>  30
<211>  94
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD5 peptide

<400>  30

Tyr Lys Lys Leu Val Lys Lys Phe Arg Gln Lys Lys Gln Arg Gln Trp 
1               5                   10                  15      


Ile Gly Pro Thr Gly Met Asn Gln Asn Met Ser Phe His Arg Asn His 
            20                  25                  30          


Thr Ala Thr Val Arg Ser His Ala Glu Asn Pro Thr Ala Ser His Val 
        35                  40                  45              


Asp Asn Glu Tyr Ser Gln Pro Pro Arg Asn Ser His Leu Ser Ala Tyr 
    50                  55                  60                  


Pro Ala Leu Glu Gly Ala Leu His Arg Ser Ser Met Gln Pro Asp Asn 
65                  70                  75                  80  


Ser Ser Asp Ser Asp Tyr Asp Leu His Gly Ala Gln Arg Leu 
                85                  90                  


<210>  31
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD8 alpha peptide

<400>  31

Asn His Arg Asn Arg Arg Arg Val Cys Lys Cys Pro Arg Pro Val Val 
1               5                   10                  15      


Lys Ser Gly Asp Lys Pro Ser Leu Ser Ala Arg Tyr Val 
            20                  25                  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD8 beta peptide

<400>  32

Arg Arg Arg Arg Ala Arg Leu Arg Phe Met Lys Gln Phe Tyr Lys 
1               5                   10                  15  


<210>  33
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD28 peptide

<400>  33

Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro 
1               5                   10                  15      


Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro 
            20                  25                  30          


Arg Asp Phe Ala Ala Tyr Arg Ser 
        35                  40  


<210>  34
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD137 TNF receptor member 9 peptide

<400>  34

Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met 
1               5                   10                  15      


Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe 
            20                  25                  30          


Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu 
        35                  40          


<210>  35
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD134 TNF receptor member 4

<400>  35

Arg Arg Asp Gln Arg Leu Pro Pro Asp Ala His Lys Pro Pro Gly Gly 
1               5                   10                  15      


Gly Ser Phe Arg Thr Pro Ile Gln Glu Glu Gln Ala Asp Ala His Ser 
            20                  25                  30          


Thr Leu Ala Lys Ile 
        35          


<210>  36
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-cell costimulator (ICOS) peptide

<400>  36

Lys Lys Lys Tyr Ser Ser Ser Val His Asp Pro Asn Gly Glu Tyr Met 
1               5                   10                  15      


Phe Met Arg Ala Val Asn Thr Ala Lys Lys Ser Arg Leu Thr Asp Val 
            20                  25                  30          


Thr Leu 
        


<210>  37
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD28 transmembrane peptide

<400>  37

Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu 
1               5                   10                  15      


Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg 
            20                  25              


<210>  38
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GITR, TNF receptor member 18 transmembrane element

<400>  38

Pro Leu Gly Trp Leu Thr Val Val Leu Leu Ala Val Ala Ala Cys Val 
1               5                   10                  15      


Leu Leu Leu Thr Ser Ala 
            20          


<210>  39
<211>  61
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD8 alpha hinge region

<400>  39

Leu Ser Asn Ser Ile Met Tyr Phe Ser His Phe Val Pro Val Phe Leu 
1               5                   10                  15      


Pro Ala Lys Pro Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala 
            20                  25                  30          


Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg 
        35                  40                  45              


Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp 
    50                  55                  60      


<210>  40
<211>  61
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD8 beta spacer element peptide

<400>  40

Val Asp Phe Leu Pro Thr Thr Ala Gln Pro Thr Lys Lys Ser Thr Leu 
1               5                   10                  15      


Lys Lys Arg Val Cys Arg Leu Pro Arg Pro Glu Thr Gln Lys Gly Pro 
            20                  25                  30          


Leu Cys Ser Pro Ile Thr Leu Gly Leu Leu Val Ala Gly Val Leu Val 
        35                  40                  45              


Leu Leu Val Ser Leu Gly Val Ala Ile His Leu Cys Cys 
    50                  55                  60      


<210>  41
<211>  82
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD4 315-396 spacer element

<400>  41

Val Val Met Arg Ala Thr Gln Leu Gln Lys Asn Leu Thr Cys Glu Val 
1               5                   10                  15      


Trp Gly Pro Thr Ser Pro Lys Leu Met Leu Ser Leu Lys Leu Glu Asn 
            20                  25                  30          


Lys Glu Ala Lys Val Ser Lys Arg Glu Lys Ala Val Trp Val Leu Asn 
        35                  40                  45              


Pro Glu Ala Gly Met Trp Gln Cys Leu Leu Ser Asp Ser Gly Gln Val 
    50                  55                  60                  


Leu Leu Glu Ser Asn Ile Lys Val Leu Pro Thr Trp Ser Thr Pro Val 
65                  70                  75                  80  


Gln Pro 
        


<210>  42
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CD28 137-152 spacer element peptide

<400>  42

Gly Lys His Leu Cys Pro Ser Pro Leu Phe Pro Gly Pro Ser Lys Pro 
1               5                   10                  15      


<210>  43
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TNF receptor member 19 peptide

<400>  43

Arg Ser Gln Cys Met Trp Pro Arg Glu Thr Gln Leu Leu Leu Glu Val 
1               5                   10                  15      


Pro Pro Ser Thr Glu Asp Ala Arg Ser Cys Gln Phe Pro Glu Glu Glu 
            20                  25                  30          


Arg Gly Glu Arg Ser Ala Glu Glu Lys Gly Arg Leu Gly Asp Leu Trp 
        35                  40                  45              


Val 
    


<210>  44
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from CD24

<400>  44

Thr Asn Ala Thr Thr Lys Ala Ala Gly Gly Ala Leu Gln Ser Thr Ala 
1               5                   10                  15      


Ser Leu Phe Val Val Ser Leu Ser Leu Leu His Leu Tyr Ser 
            20                  25                  30  


<210>  45
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from CNTN1

<400>  45

Val Ser Gln Val Lys Ile Ser Gly Ala Pro Thr Leu Ser Pro Ser Leu 
1               5                   10                  15      


Leu Gly Leu Leu Leu Pro Ala Phe Gly Ile Leu Val Tyr Leu Glu Phe 
            20                  25                  30          


<210>  46
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from EFNA1

<400>  46

Pro Glu Val Arg Val Leu His Ser Ile Gly His Ser Ala Ala Pro Arg 
1               5                   10                  15      


Leu Phe Pro Leu Ala Trp Thr Val Leu Leu Leu Pro Leu Leu Leu Leu 
            20                  25                  30          


Gln Thr Pro 
        35  


<210>  47
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from EFNA2

<400>  47

Glu Ala Pro Glu Pro Ile Phe Thr Ser Asn Asn Ser Cys Ser Ser Pro 
1               5                   10                  15      


Gly Gly Cys Arg Leu Phe Leu Ser Thr Ile Pro Val Leu Trp Arg Leu 
            20                  25                  30          


Leu Gly Ser 
        35  


<210>  48
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from EFNA3

<400>  48

Gln Val Pro Lys Leu Glu Lys Ser Ile Ser Gly Thr Ser Pro Lys Arg 
1               5                   10                  15      


Glu His Leu Pro Leu Ala Val Gly Ile Ala Phe Phe Leu Met Thr Phe 
            20                  25                  30          


Leu Ala Ser 
        35  


<210>  49
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from EFNA5

<400>  49

Glu Ser Ala Glu Pro Ser Arg Gly Glu Asn Ala Ala Gln Thr Pro Arg 
1               5                   10                  15      


Ile Pro Ser Arg Leu Leu Ala Ile Leu Leu Phe Leu Leu Ala Met Leu 
            20                  25                  30          


Leu Thr Leu 
        35  


<210>  50
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from FOLI

<400>  50

Tyr Ala Ala Ala Met Ser Gly Ala Gly Pro Trp Ala Ala Trp Pro Phe 
1               5                   10                  15      


Leu Leu Ser Leu Ala Leu Met Leu Leu Trp Leu Leu Ser 
            20                  25                  


<210>  51
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from LSAMP

<400>  51

Ser Val Arg Gly Ile Asn Gly Ser Ile Ser Leu Ala Val Pro Leu Trp 
1               5                   10                  15      


Leu Leu Ala Ala Ser Leu Leu Cys Leu Leu Ser Lys Cys 
            20                  25                  


<210>  52
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from PPB1

<400>  52

Thr Thr Asp Ala Ala His Pro Gly Arg Ser Val Val Pro Ala Leu Leu 
1               5                   10                  15      


Pro Leu Leu Ala Gly Thr Leu Leu Leu Leu Glu Thr Ala Thr Ala Pro 
            20                  25                  30          


<210>  53
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPI signal sequence from RTN4R

<400>  53

Asp Ser Glu Gly Ser Gly Ala Leu Pro Ser Leu Thr Cys Ser Leu Thr 
1               5                   10                  15      


Pro Leu Gly Leu Ala Leu Val Leu Trp Thr Val Leu Gly Pro Cys 
            20                  25                  30      


